Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;22(1):57-64.
doi: 10.1111/jch.13761. Epub 2019 Dec 9.

Utilization of antihypertensive drugs among chronic kidney disease patients: Results from the Chinese cohort study of chronic kidney disease (C-STRIDE)

Bianling Liu  1   2 , Qin Wang  1 , Yu Wang  1 , Jinwei Wang  1 , Luxia Zhang  1 , Minghui Zhao  1 ; C-STRIDE study group
Affiliations

Utilization of antihypertensive drugs among chronic kidney disease patients: Results from the Chinese cohort study of chronic kidney disease (C-STRIDE)

Bianling Liu et al. J Clin Hypertens (Greenwich). 2020 Jan.

Abstract

The utilization of antihypertensive drugs plays an important role in blood pressure control among chronic kidney disease (CKD) patients. Limited information was available on how antihypertensive drugs were used among Chinese CKD patients. In the present study, the utilization of antihypertensive drugs among a subgroup of hypertensive participants with a complete record of antihypertensive drug information from the Chinese Cohort Study of Chronic Kidney Disease was analyzed. Among 2213 subjects, 61.7% and 26.5% had their blood pressure controlled to <140/90 mmHg and <130/80 mmHg, respectively. In total, 38.5% were on monotherapy. Of those patients who received combination therapy, 57.8% were treated with a two-drug combination. Renin-angiotensin system inhibitors (RASIs) were the most commonly prescribed drugs (71.2%). Only 10.2% of the patients were prescribed diuretics. After multivariable adjustment, participants taking RASI were more likely to have their blood pressure controlled to <140/90 mmHg (prevalence ratio (PR) 1.153, 95% confidence interval (CI): 1.071-1.240). CKD stage 4 (PR 0.548, 95% CI: 0.434-0.692) was associated with RASIs treatment. Additionally, diabetes (PR 1.498, 95% CI: 1.120-2.004), albumin/creatinine ratio ≥300 mg/g (PR 1.547, 95% CI: 1.020-2.344), and CKD stage 4 (PR 2.022, 95% CI: 1.223-3.343) were associated with diuretic use. The results suggested that combination therapy, diuretics use in general, and utilization of RASIs in advanced CKD stage were insufficient in the current treatment of Chinese hypertensive CKD patients.

Keywords: antihypertensive therapy; chronic kidney disease; diuretic; hypertension; renin-angiotensin system inhibitor.

PubMed Disclaimer

Conflict of interest statement

The authors report no specific funding in relation to this research and have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Utilization pattern of antihypertension drugs in different CKD stages. A. Percentage of the number of antihypertension drugs utilized in the cohort; B. percentage of the number of antihypertension drugs utilized in the combination group; C. percentage of the number of antihypertension drugs utilized in each CKD stage
Figure 2
Figure 2
Utilization of different antihypertension drug classes in different CKD stages. ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker
See this image and copyright information in PMC

References

    1. The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the management of blood pressure in Chronic Kidney Disease. Kidney Int Supplement. 2012;2:337.
    1. Wang YU, Zhang L, Li X, et al. Improvement of awareness, treatment and control of hypertension among chronic kidney disease patients in China from 1999 to 2005. Hypertens Res. 2009;32(6):444‐449. - PubMed
    1. Zheng Y, Cai GY, Chen XM, et al. Prevalence, awareness, treatment, and control of hypertension in the non‐dialysis chronic kidney disease patients. Chin Med J. 2013;126(12):2276‐2280. - PubMed
    1. Zhang W, Shi W, Liu Z, et al. A nationwide cross‐sectional survey on prevalence, management and pharmacoepidemiology patterns on hypertension in Chinese patients with chronic kidney disease. Sci Rep. 2016;6:38768. - PMC - PubMed
    1. Yan Z, Wang YU, Li S, et al. Hypertension control in adults with CKD in China: baseline results from the Chinese cohort study of chronic kidney disease (C‐STRIDE). Am J Hypertens. 2018;31(4):486‐494. - PubMed

Publication types

MeSH terms